SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike is experiencing significant trading activity and debate following its latest earnings report, which showed a beat on top and bottom lines but triggered a sharp decline due to concerns over weak guidance, shrinking margins, and continued softness in China. The community is polarized, with many seeing a "generational buying opportunity" for the oversold brand, while others emphasize increasing competition and ongoing tariff impacts as reasons for further downside.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is a major topic as community chatter intensifies around its "physical AI" initiatives, particularly recent Cybercab testing sightings and renewed promises for its Full Self-Driving capabilities. Bulls are driving conversation by focusing on the transformative potential of these advancements, while a skeptical segment questions the stock's valuation and current fundamentals amidst broader market dynamics.

Flora Growth Corp. engages in the production of organic cannabis and pharmaceutical-grade medical products. It operates through the following segments: House of Brands and Commercial and Wholesale. The House of Brands segment includes multiple categories including food and beverage, nutraceuticals, cannabis accessories and technology, personal care and wellness. The Commercial and Wholesale segment includes distribution of pharmaceutical products to international markets. The company was founded on March 13, 2019 and is headquartered in Fort Lauderdale, FL.

Flora Growth Corp

Flora Growth Corp. is trending due to its recent strategic pivot, rebranding as ZeroStack and securing substantial funding for a new digital asset treasury focused on the AI-first 0G blockchain. This dramatic shift is fueling community speculation, with many highlighting the company's historically low public float as a potential catalyst for significant price volatility, though some voices urge caution given past trading patterns.

WhiteFiber, Inc. provides AI and HPC infrastructure & cloud and data center solutions. It operates through the following segments: Cloud Services and Colocation Services. The Cloud Services segment offers computing services to support generative AI workstreams. The Colocation Services segment provides customers with physical space, power and cooling within the data center facility. The company was founded on August 15, 2024 and is headquartered in New York, NY.

Whitefiber Inc.

WhiteFiber, Inc.

WhiteFiber (WYFI) is trending following the announcement of a significant 10-year, $865 million colocation agreement with Nscale for its NC-1 data center campus, aligning with the surging demand for AI infrastructure. This deal, which will power AI infrastructure for global technology customers and is linked to Microsoft Azure, positions WYFI as a key player in the AI data center race, drawing community discussion around its substantial revenue visibility and potential for future expansion. Investors are also noting WYFI's low float and strong analyst upgrades, fueling speculation about its undervalued status and multi-day runner potential in the high-demand AI sector.

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Intuitive Machines (LUNR) is trending with strong community buzz, fueled by recent positive analyst coverage and high anticipation for a pivotal NASA Lunar Terrain Vehicle (LTV) contract award. Investors are eyeing its strategic role in the burgeoning lunar economy, coupled with a renewed White House focus on American space superiority and the potential for significant short interest to drive further momentum.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group is trending following news of its multi-billion dollar all-stock merger with fusion energy firm TAE Technologies, signaling a significant strategic pivot from social media. This development has sparked fervent community debate, with bulls envisioning immense future potential in clean energy and AI, while skeptics point to DJT's volatile history and the highly speculative nature of commercial fusion power.

Oracle Corp. engages in the provision of products and services that address aspects of corporate information technology environments, including applications and infrastructure technologies. It operates through the following business segments: Cloud and License, Hardware, and Services. The Cloud and License segment markets, sells, and delivers enterprise applications and infrastructure technologies through cloud and on-premise deployment models including cloud services and license support offerings. The Hardware segment provides infrastructure technologies including Oracle Engineered Systems, servers, storage, industry-specific hardware, operating systems, virtualization, management, and other hardware-related software. The Services segment offers consulting, advanced support, and education services. The company was founded by Lawrence Joseph Ellison, Robert Nimrod Miner, and Edward A. Oates on June 16, 1977 and is headquartered in Austin, TX.

Oracle Corp.

Oracle is trending following the finalized agreement for a TikTok US joint venture, where it secures a significant investor role and becomes the crucial overseer for data and algorithms. This move is widely seen by the community as a powerful validation of Oracle's cloud infrastructure and a potential catalyst to counter recent concerns over its debt-fueled AI expansion, leading many to anticipate a short squeeze.

FedEx Corp. is a holding company, which engages in the provision of transportation, e-commerce, business services, and business solutions. It operates through the following segments: FedEx Express, FedEx Freight, Corporate, Other, and Eliminations. The FedEx Express segment offers transportation and delivery services. The FedEx Freight segment refers to freight transportation services to business and residences. The FedEx Services segment includes sales, marketing, information technology, communications, customer service, technical support, billing and collection services, and certain back-office functions that support the company's operating segments. The Corporate, Other, and Eliminations segment is involved in the corporate headquarters costs for executive officers and certain legal and finance functions, as well as certain other costs and credits not attributed to the firm's core business. The company was founded by Frederick Wallace Smith on June 18, 1971, and is headquartered in Memphis, TN.

Fedex Corp

FedEx is trending due to a significant earnings and revenue beat, coupled with a raised fiscal year outlook attributed to successful cost-cutting and network transformation efforts. The community is largely bullish on the strong performance and strategic initiatives, though some discussions highlight caution around options volatility and potential impacts from trade headwinds. This positive momentum comes as FedEx continues to streamline operations in a dynamic global logistics landscape.

Starfighters Space Inc

Starfighters Space Inc (FJET) is generating significant buzz following its recent IPO, with many in the community touting it as a potential "birth of a giant" in the space sector. Traders are actively discussing its high volatility and low float characteristics, positioning it as a momentum play with potential for premarket runs.

Redacted is a multi-vertical Web3 ecosystem focused on bridging Real-World Assets (RWA) with on-chain accessibility. It powers products across RWA, DeFi, GameFi and Creator Platforms through its ecosystem token $RDAC. Following its merger with Tenset in October 2025, Redacted became the ecosystem layer uniting token launches and RWA participation under a single, scalable framework serving both institutional and retail users.

Redacted

RDAC is trending due to its exceptionally low public float, fueling speculation among traders for a significant short squeeze. The community is actively discussing its potential to replicate the explosive upward movements recently observed in other low-float SPACs, positioning it as a focus for high-volatility trading.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Johnson & Johnson $JNJ Shares Bought by Czech National Bank

Czech National Bank grew its stake in shares of Johnson & Johnson (NYSE:JNJ - Free Report) by 4.0% in the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission...

Johnson & Johnson $JNJ Shares Sold by Chesley Taft & Associates LLC

Chesley Taft & Associates LLC lowered its holdings in shares of Johnson & Johnson (NYSE:JNJ - Free Report) by 2.6% during the 3rd quarter, according to its most recent 13F filing with the Securities...

J&J Wins FDA Nod for Subcutaneous Version of NSCLC Drug Rybrevant

JNJ wins FDA approval for a subcutaneous version of Rybrevant, cutting treatment time to minutes and boosting convenience across NSCLC indications.

3 Cancer Stocks to Buy Amid Rapid Advances in Cancer Treatment

J&J, ImmunityBio and Foghorn Therapeutics stand out as oncology players amid rapid innovation in cancer care with advancing pipelines, approvals and partnerships.

U.S. FDA Approval of RYBREVANT FASPRO (amivantamab and hyaluronidase-lpuj) Enables the Simplest, Shortest Administration Time for a First-Line Combination Regimen when Combined with LAZCLUZE (lazertinib)

U.S. FDA Approval of RYBREVANT FASPRO (amivantamab and hyaluronidase-lpuj) Enables the Simplest, Shortest Administration Time for a First-Line Combination Regimen when Combined with LAZCLUZE...

<ul class="summary-bullets"><li>The talks follow the administration’s push to lower U.S. drug prices using trade and regulatory leverage.</li><li>Pfizer and AstraZeneca have already reached agreements, while several other major drugmakers are still weighing potential deals.</li><li>Novartis and Roche have highlighted U.S. investment and manufacturing commitments.</li></ul><p>Novartis' U.S.-listed stock rose on Wednesday as investors weighed reports of impending U.S. drug pricing deals tied to the company.</p><p>The announcement is expected as soon as Friday and could include Roche, though details are still being finalized and additional drugmakers may be added, according to a&nbsp;<a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.bloomberg.com/news/articles/2025-12-17/novartis-roche-near-us-drug-price-deal-in-easing-of-swiss-trade-tensions">report</a> by Bloomberg.</p><h2 class="st-heading-2"><strong>Trump’s Push On Drug Prices</strong></h2><p>In August,&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/trump-turns-up-heat-on-big-pharma-ce-os-to-slash-drug-prices-within-60-days-but-retail-traders-don-t-flinch/chr3jLYRdGW">Trump sent letters to 17 pharmaceutical companies</a> demanding that they cut prices for U.S. government insurance programs and align domestic pricing more closely with what patients pay in other developed countries. The letters also called for companies to make medicines available through a Trump-branded direct-to-consumer platform and commit to not charging Americans more than foreign markets under a “most-favored-nation” pricing framework.</p><p>In exchange, companies were offered multiyear relief from threatened tariffs and some potential regulatory measures. The administration has said it is using trade policy as leverage to force price reductions, arguing that Americans pay more than triple what patients in other developed nations pay for the same drugs.</p><h2 class="st-heading-2"><strong>Who Has And Hasn’t Cut Deals</strong></h2><p>Pfizer and AstraZeneca have already struck agreements with the administration in recent months, but many other drugmakers are still on the sidelines. Companies such as AbbVie, Bristol-Myers Squibb, Gilead Sciences, Amgen, Johnson &amp; Johnson, Merck, Regeneron Pharmaceuticals and Sanofi have yet to announce any deals.</p><p>Novartis said in a statement to Bloomberg it is in talks with the administration and is committed to lowering U.S. drug costs while addressing price gaps with other developed countries. Meanwhile, Roche’s Genentech unit said it supports efforts to reduce U.S. prices while urging other nations to better reward biopharmaceutical innovation.</p><p>The White House cautioned that no deal is final. “Until officially announced by President Trump or the Administration, any reporting about potential dealmaking is speculation,” spokesman Kush Desai told the news outlet.</p><h2 class="st-heading-2"><strong>Manufacturing Commitments&nbsp;</strong></h2><p>Domestic manufacturing has played a central role in negotiations. Novartis has stepped up its U.S. footprint, with CEO Vas Narasimhan recently attending the opening of a new manufacturing facility in North Carolina alongside FDA Commissioner Marty Makary.</p><p>The company plans to invest $23 billion in the U.S. over the next five years and generate about 41% of its revenue from the market, led by drugs such as Entresto. Roche has also committed to expanding in the U.S., pledging $50 billion in investment and deriving nearly half of its revenue from the country, driven by treatments including Ocrevus and Tecentriq.</p><h2 class="st-heading-2"><strong>How Did Stocktwits Users React?</strong></h2><p>On Stocktwits, retail sentiment for Novartis was ‘bearish’ with ‘low’ message volume, while Roche was ‘bullish’ amid ‘high’ message volume.</p><p>So far this year,&nbsp;<a href="https://stocktwits.com/symbol/NVS">Novartis’ U.S.-listed shares</a> have risen 42%, while&nbsp;<a href="https://stocktwits.com/symbol/RHHBY">Roche’s U.S.-listed stock</a> has also gained 45% over the same period.</p><p>For updates and corrections, email newsroom[at]stocktwits[dot]com.</p>

In this photo illustration, the Novartis company logo is seen displayed on a smartphone screen. (Photo Illustration by Piotr Swat/SOPA Images/LightRocket via Getty Images)

Novartis US Stock Rises On Reports Of White House Pricing Deal Due Friday — Roche Also In Talks

The potential agreements would mark another step in Washington’s broader effort to reshape drug pricing.

Equity

Medical Stocks To Research - December 17th

Eli Lilly and Company, UnitedHealth Group, Pfizer, Johnson & Johnson, Boston Scientific, Thermo Fisher Scientific, and AbbVie are the seven Medical stocks to watch today, according to MarketBeat's...

Best Healthcare Stocks To Research - December 17th

UnitedHealth Group, Johnson & Johnson, and Intuitive Surgical are the three Healthcare stocks to watch today, according to MarketBeat's stock screener tool. Healthcare stocks are shares of publicly...

Is Trending Stock Johnson & Johnson (JNJ) a Buy Now?

Zacks.com users have recently been watching Johnson & Johnson (JNJ) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.

Iowa State Bank Sells 7,472 Shares of Johnson & Johnson $JNJ

Iowa State Bank lowered its stake in Johnson & Johnson (NYSE:JNJ - Free Report) by 16.7% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange...

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in the interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Johnson & Johnson

Up more than 2%

Up 0–2%

Flat to down 2%

Down more than 2%

The S&P 500 is modestly lower so far in December, putting the Santa Claus rally in question. The Santa Claus rally refers to the market’s tendency to rise in the final weeks of the year—what do you expect from December 16 through December 31?

What do you expect the S&amp;P 500’s total return to be in the second half of December?

Stocktwits

What do you expect the S&P 500’s total return to be in the second half of December?

JNJ
Johnson & Johnson

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest JNJ News

JNJJohnson & Johnson